Amikalla-M 250 Injection
Marketer
Skylla Pharmaceuticals
Salt Composition
Amikacin (250mg)
Overview Amikalla-M 250 Injection
Amikacin 250mg injection combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections, among others. Prophylactic use is also indicated in hospitalized patients. Its mechanism involves bacterial growth inhibition. Administered intravenously (drip) or intramuscularly by a healthcare professional only, it requires regular, evenly-spaced doses as directed. Complete the prescribed course; premature cessation risks relapse or infection exacerbation. Injection site reactions and elevated blood urea nitrogen are common adverse effects; persistent symptoms or treatment ineffectiveness necessitate medical consultation. High doses may cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is crucial, including potential monitoring via kidney function, hearing, and urine tests. Pregnancy contraindicates its use; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Amikalla-M 250 Injection
Infections caused by bacteria
Major Benefits of Amikalla-M 250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Amikalla-M 250 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Amikalla-M 250 Injection:
Administering this medication will be performed by your physician or registered nurse; self-medication is strictly prohibited.
How Amikalla-M 250 Injection works:
Amikacin 250mg injection is a bactericidal antibiotic that inhibits bacterial protein synthesis, thereby disrupting crucial bacterial processes.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Amikalla-M 250 Injection poses no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Amikacin 250mg injection poses a confirmed risk to a developing fetus and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Amikacin 250 mg injection poses minimal risk to breastfeeding infants. Research in humans indicates negligible transfer into breast milk, rendering it unlikely to harm the nursing child.
DrivingUNSAFE
Amikalla-M 250 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Amikalla-M 250 Injection requires careful administration for individuals with impaired kidney function. Dosage modification of Amikalla-M 250 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Amikacin 250 mg injection is likely safe for individuals with hepatic impairment. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Amikalla-M 250 Injection :
Omit a dose of Amikalla-M 250 Injection? Seek your physician's advice.
Facts to Know About Amikalla-M 250 Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently